More than 900 biologic drugs and vaccines are being developed as possible treatments for more than 100 illnesses, according to a report by PhRMA. PhRMA CEO John J. Castellani said regulatory and public policy support is needed to keep that pipeline growing. The therapies in development include 58 cardiovascular disease treatments, 71 autoimmune disease drugs, 176 treatments for infectious diseases and 338 cancer medicines.

Full Story:
The Burrill Report

Related Summaries